scorecardresearch52-week low: Gland Pharma cracks 12%; brokerages remain mixed after Q1 result

52-week low: Gland Pharma cracks 12%; brokerages remain mixed after Q1 result

Updated: 21 Jul 2022, 02:15 PM IST
TL;DR.
  • Gland Pharma, which is a generic injectable-focused pharmaceutical company, reported a 26% year-on-year (YoY) fall in revenue from operations for Q1FY23 at 856.9 crore.
Gland Pharma's Q1FY23 results were below market expectations. Photo: PIxabay

Gland Pharma's Q1FY23 results were below market expectations. Photo: PIxabay